ddPCR technology drives progress in oncology research
Pioneering research into ddPCR technology by two leading scientists is advancing research in oncology
Pioneering research into ddPCR technology by two leading scientists is advancing research in oncology
New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions
Automated workflows from single-cell dispensing to 3D spheroid analysis
Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s disease
Explore the world of epigenomics and its impact on cancer research in conversation with Dr. Jorg Tost and Prof. Martin Hirst
Good documentation of lab processes and equipment is essential for safe and efficient projects
Advancing drug discovery and development through cutting-edge innovations
Explore the products you’ve told us are advancing science and research in Life Sciences
SelectScience editors will be reporting the latest news from this year’s analytica conference. Detailed here, are some of the key things to look out for
Dr. Ronan Chaligné, Head of the Single-Cell Analytics Innovation Laboratory, discusses advances in single-cell methods advancing cancer research
The epigenomic signature is evident prior to CD19-targeted CAR T-cell treatment
New study hopes to advance climate change ecology by highlighting the importance of plant root phenology
Find out how unbiased lab product reviews are changing the world of science - and why not get involved yourself?
Both vaccines are highly effective and either one is strongly recommended
In this guest editorial, discover how genome editing in iPSCs can be a powerful tool to investigate the intricacies of the human genome
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models
Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
New system provides end-to-end solution for researchers to validate specificity of CRISPR and other genome editing projects
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses
Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline
Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience